These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34554592)

  • 41. [Dowling-Degos disease and chronic hidradenitis suppurativa].
    Rammeh Rommani S; Ajouli W; Fazaa B; Khaled A; Zermani R
    Ann Dermatol Venereol; 2013 Dec; 140(12):838-40. PubMed ID: 24315237
    [No Abstract]   [Full Text] [Related]  

  • 42. Hidradenitis suppurativa from the typical patient to the new clinical phenotypes.
    Hristakieva E; Manuelyan K; Gancheva T; Lavcheva R; Deliyska R
    Clin Dermatol; 2023; 41(5):584-591. PubMed ID: 37652191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutrophilic Dermatoses in a Clinical Practice of Wound Care Professionals.
    Lapa T; Sibbald RG; Coutts PM; Zhao XC
    Adv Skin Wound Care; 2022 Jun; 35(6):1-8. PubMed ID: 35703854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyoderma gangrenosum after silicone prosthesis implant in the breasts and facial plastic surgery.
    Bonamigo RR; Behar PR; Beller C; Bonfá R
    Int J Dermatol; 2008 Mar; 47(3):289-91. PubMed ID: 18289335
    [No Abstract]   [Full Text] [Related]  

  • 45. Facial superficial granulomatous pyoderma treated with cyclosporin: not always a benign condition.
    Cheung ST; Zanetto U; Diaz C
    Acta Derm Venereol; 2006; 86(4):362-4. PubMed ID: 16874429
    [No Abstract]   [Full Text] [Related]  

  • 46. Superficial Granulomatous Pyoderma Gangrenosum Involving the Face: A Case Series of Five Patients and a Review of the Literature [Formula: see text].
    Shavit E; Cecchini M; Limacher JJ; Walsh S; Wentworth A; Davis MDP; Alavi A
    J Cutan Med Surg; 2021; 25(4):371-376. PubMed ID: 33541119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial Mediterranean fever patients with hidradenitis suppurativa.
    Vural S; Gundogdu M; Kundakci N; Ruzicka T
    Int J Dermatol; 2017 Jun; 56(6):660-663. PubMed ID: 28194777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma).
    Mantovani L; Zauli S; Sarno O; Querzoli P; Corazza M; Virgili A
    Int J Dermatol; 2013 Jun; 52(6):753-6. PubMed ID: 23330662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: A population-based analysis in the United States.
    Tannenbaum R; Strunk A; Garg A
    J Am Acad Dermatol; 2019 Jun; 80(6):1533-1537. PubMed ID: 30738122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyoderma gangrenosum in a patient with systemic sclerosis.
    Feld J; Bergman R; Weltfriend S; Zisman D
    J Rheumatol; 2012 Jan; 39(1):197. PubMed ID: 22210685
    [No Abstract]   [Full Text] [Related]  

  • 51. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature.
    Vekic DA; Woods J; Lin P; Cains GD
    Int J Dermatol; 2018 Jan; 57(1):10-18. PubMed ID: 28884797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-dose methotrexate as rescue therapy in patients with hidradenitis suppurativa and pyoderma gangrenosum developing human antichimeric antibodies to infliximab: A retrospective chart review.
    Wang LL; Micheletti RG
    J Am Acad Dermatol; 2020 Feb; 82(2):507-510. PubMed ID: 31541746
    [No Abstract]   [Full Text] [Related]  

  • 53. The use of hyperbaric oxygen therapy in the treatment of necrotizing soft tissue infections, compromised grafts and flaps, hidradenitis suppurativa, and pyoderma gangrenosum.
    Goggins CA; Khachemoune A
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Jun; 28(2):81-84. PubMed ID: 31233172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.
    Marzano AV; Borghi A; Meroni PL; Cugno M
    Br J Dermatol; 2016 Nov; 175(5):882-891. PubMed ID: 27106250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wegener's granulomatosis presenting as pyoderma gangrenosum.
    Handfield-Jones SE; Parker SC; Fenton DA; Newton JA; Greaves MW
    Clin Exp Dermatol; 1992 May; 17(3):197-200. PubMed ID: 1451301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome.
    Calderón-Castrat X; Bancalari-Díaz D; Román-Curto C; Romo-Melgar A; Amorós-Cerdán D; Alcaraz-Mas LA; Fernández-López E; Cañueto J
    Br J Dermatol; 2016 Jul; 175(1):194-8. PubMed ID: 26713508
    [No Abstract]   [Full Text] [Related]  

  • 57. Superficial granulomatous pyoderma gangrenosum of the face, successfully treated by ciclosporine: a long-term follow-up.
    Lachapelle JM; Marot L; Jablonska S
    Dermatology; 2001; 202(2):155-7. PubMed ID: 11306846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bullous pyoderma gangrenosum as a manifestation of leukemia cutis.
    Török L; Kirschner A; Gurzó M; Krenács L
    Eur J Dermatol; 2000 Aug; 10(6):463-5. PubMed ID: 10980469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases.
    Marzano AV; Ceccherini I; Gattorno M; Fanoni D; Caroli F; Rusmini M; Grossi A; De Simone C; Borghi OM; Meroni PL; Crosti C; Cugno M
    Medicine (Baltimore); 2014 Dec; 93(27):e187. PubMed ID: 25501066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
    Marzano AV; Damiani G; Ceccherini I; Berti E; Gattorno M; Cugno M
    Br J Dermatol; 2017 Jun; 176(6):1588-1598. PubMed ID: 27943240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.